miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer

FEBS Letters
Zeng HuiLi Hui

Abstract

The involvement of miR-491-5p in breast cancer development is unclear. This study showed that miR-491-5p is significantly downregulated in ERα-positive breast cancer tissues and cell lines and is generally hypermethylated in ERα-positive breast cancer. MiR-491-5p overexpression significantly suppressed estrogen signaling and estrogen-stimulated proliferation of breast cancer cells. Furthermore, the histone demethylase JMJD2B was identified as a direct target of miR-491-5p. The ectopic expression of JMJD2B abrogated the phenotypic changes induced by miR-491-5p in breast cancer cells. Collectively, our data indicate that miR-491-5p plays a tumor suppressor role in the development and progression of breast caner and may be a novel therapeutic target against ERα-positive breast cancer.

References

Jun 7, 2003·Endocrine-related Cancer·S F Doisneau-SixouR L Sutherland
Mar 25, 2006·Nature Reviews. Cancer·Aurora Esquela-Kerscher, Frank J Slack
Aug 31, 2006·Molecular and Cellular Biology·Anwar HossainGrady F Saunders
May 6, 2009·Molecular and Cellular Biology·Deo Prakash Pandey, Didier Picard
Jun 10, 2009·Breast Cancer Research and Treatment·Marc P J McCaffertyMichael J Kerin
Nov 7, 2009·Seminars in Cell & Developmental Biology·Mareike Albert, Kristian Helin
Jul 28, 2010·Nature Reviews. Genetics·Jacek KrolWitold Filipowicz
Nov 9, 2010·Annual Review of Medicine·Simak AliR Charles Coombes
Apr 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Lei ShiYongfeng Shang
Jul 15, 2011·Breast Cancer Research and Treatment·Nobuyasu YoshimotoHiroko Yamashita
Nov 25, 2011·Breast Cancer Research : BCR·Yee-Ming LeeHuei-Wen Chen
Feb 9, 2012·Proceedings of the National Academy of Sciences of the United States of America·Stefano VoliniaCarlo M Croce
Dec 4, 2012·Molecular Cell·Joshua C BlackJohnathan R Whetstine
Feb 26, 2013·Nucleic Acids Research·Kelly CoffeyCraig N Robson
Jan 1, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rong GuoLi Liu
May 7, 2013·Cancer Research·William L Berry, Ralf Janknecht
Jun 1, 2013·Nucleic Acids Research·Luke GaughanCraig N Robson
Jun 4, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Yun ZhouJianping Zhang
Oct 24, 2013·Molecular Oncology·Suvi-Katri LeivonenMerja Perälä
Mar 22, 2014·Expert Review of Molecular Diagnostics·Laoighse MulraneDarran P O'Connor

❮ Previous
Next ❯

Citations

Mar 9, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Gaia PalminiMaria Luisa Brandi
Mar 14, 2018·International Journal of Radiation Biology·Tünde SzatmáriKatalin Lumniczky
Feb 15, 2019·Genes·Cailin Wilson, Adam J Krieg
Apr 5, 2019·Journal of Cellular Physiology·Samira Mohammadi-YeganehMahdi Paryan
Nov 2, 2019·The International Journal of Biological Markers·Zhigang LiuRuifang Sun
Jan 22, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Dong Hoon LeeSo Hee Kwon
Jun 30, 2019·Cancers·Brock HumphriesChengfeng Yang
Jul 17, 2020·Non-coding RNA·Jun Sheng Wong, Yoke Kqueen Cheah
Apr 1, 2021·The Journal of Gene Medicine·Jiali WuShengping Li
May 29, 2021·Environmental Science and Pollution Research International·Marwa M MahmoudNadia M Hamdy
Jul 15, 2021·Pathology Oncology Research : POR·Juanjuan DaiYan Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.